A new blood pressure medication has been approved in the U.S., but this one isn't quite like others that help treat hypertension. Baxfendy, from pharmaceutical maker AstraZeneca, is the "first and ...
Baxfendy inhibits a blood-pressure-raising enzyme and, according to AstraZeneca executives, is poised to be a “big product” ...
The pharmaceutical company expects the drug Baxfendy to generate multibillion-dollar annual sales at its peak.
After an impressive phase 3 showing last fall, AstraZeneca’s wager on CinCor Pharma and its aldosterone synthase inhibitor ...
AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive ...
Hypertension, commonly called high blood pressure, is one of the most widespread chronic conditions worldwide. It often develops without noticeable symptoms, yet it significantly increases the risk of ...
Researchers at Penn State created a soft implant called CaroFlex that may help lower high blood pressure without extra medicines.
The Healthy @Reader's Digest on MSN
Another Blood Pressure Medication Has Been Recalled Nationwide
It also treats heart conditions but is the latest in a string of drugs treating these conditions that's being flagged for ...
A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results